The Beijing Longitudinal Disability Survey in Community Elderly
BLINDSCE
2 other identifiers
observational
1,962
1 country
1
Brief Summary
The goal of this observational study is to establish the prospective cohort of the Beijing Longitudinal Disability Survey in Community Elderly (BLINDSCE) to explore the high-risk factors and preventive interventions for disability and cognitive impairment among community-dwelling adults aged 65 years and over. The main question it aims to answer is:
- What are the high-risk factors able to predict the incidence and advance of disability and cognitive impairment in community-dwelling adults aged 65 years and over?
- What are the categories of function and cognitive performance trajectory in community-dwelling adults aged 65 years and over?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 7, 2023
CompletedFirst Submitted
Initial submission to the registry
February 16, 2025
CompletedFirst Posted
Study publicly available on registry
March 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2028
March 7, 2025
March 1, 2025
5 years
February 16, 2025
March 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Disability from the individual's perspective
Disability is assessed using the 12-item World Health Organization's Disability Assessment Schedule 2.0 (WHODAS 2.0). The WHODAS 2.0 is a patient-reported disability measure, comprising six life domains involving cognition, mobility, self-care, interpersonal relationships, life activities, and participation. The total score of 12-item WHODAS 2.0 categorizes disability from no disability (score 0) to complete disability (score 48).
An average of 1 to 2 years
Disability from the medical's perspective
Disability is assessed using the basic activities of daily living (BADL) scale, the Katz Index scale. The minimum value is 0 , and the maximum value is 6. The higher the score, the better the outcome.
An average of 1 to 2 years
Disability from the medical's perspective
Disability is assessed using the instrumental activities of daily living (IADL) scale, the Lawton and Brody IADL scale. The minimum value is 0, and the maximum value is 8. The higher the score, the better the outcome.
An average of 1 to 2 years
Secondary Outcomes (13)
Cognitive impairment
An average of 1 to 2 years
Cognitive impairment
An average of 1 to 2 years
Subjective cognitive decline
An average of 1 to 2 years
Intrinsic capacity
An average of 1 to 2 years
Intrinsic capacity
An average of 1 to 2 years
- +8 more secondary outcomes
Eligibility Criteria
Community residents aged 65 years or older in Beijing
You may qualify if:
- Community-dwelling adults aged 65 years or older who reside in Beijing.
- Participants who sign an institutionally approved informed consent.
You may not qualify if:
- Participants with severe mental disorders and serious medical conditions preventing study investigation
- Participants undergoing long-term professional treatment for physical function and cognitive functioning, such as hospitalization or rehabilitation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xuanwu Hospital, Beijinglead
- Beijing Municipal Health Commissioncollaborator
Study Sites (1)
Xuanwu Hospital, Capital Medical University
Beijing, 100053, China
Related Publications (1)
Cheng S, Du X, Hou C, Liu H, Lei S, Wu Y, Yue X, Guo Y. Beijing Longitudinal Disability Survey in Community Elderly (BLINDSCE): protocol for a community-based prospective longitudinal cohort study about disability prediction model. BMJ Open. 2025 May 15;15(5):e091955. doi: 10.1136/bmjopen-2024-091955.
PMID: 40379348DERIVED
Biospecimen
Plan to obtain blood samples from some of the participants
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yansu Guo, Ph.D
Beijing Geriatric Healthcare and Disease Prevention Center, Xuanwu Hospital, Capital Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2025
First Posted
March 7, 2025
Study Start
August 7, 2023
Primary Completion (Estimated)
July 31, 2028
Study Completion (Estimated)
July 31, 2028
Last Updated
March 7, 2025
Record last verified: 2025-03